Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Disposal

7 Aug 2017 10:03

RNS Number : 2727N
Dunedin Enterprise Inv Trust PLC
07 August 2017
 

Dunedin Enterprise realisation of Blackrock PM

 

 

Dunedin Enterprise Investment Trust PLC is pleased to announce the successful realisation of its investment in Blackrock PM, the provider of independent expert witnesses to dispute and litigation resolution in the construction sector.

 

Capital and accrued interest in Blackrock was valued at £10.4m as at 31 March 2017, the last published valuation. Total proceeds from the sale amounted to £12.8m (an uplift of £2.4m, or 11.7p per share), consisting of capital of £12.7m and income of £0.1m. The original cost of the investment was £4.9m and over the life of the investment a total of £13.9m was received by Dunedin Enterprise representing a 2.8 times return and an IRR of 60%.

 

The Board is keeping under review the cash and outstanding commitment position of the Company. Following the realisation of Blackrock, the Company will have cash balances of £16.4m with outstanding commitments to limited partnership funds of £28.5m. It is estimated that approximately £13m of this total commitment will be drawn over the remaining life of the limited partnership funds. It is not the current intention of the Board to make a capital distribution to shareholders until there are further realisations from the portfolio.

 

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISGCGDIBGGBGRR
Date   Source Headline
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.